BLUEPRINT MEDICINES CORP's ticker is and the CUSIP is 09627Y959. A total of 4 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,392,384 | +59.1% | 147,200 | +100.3% | 0.00% | 0.0% |
| Q2 2023 | $4,645,200 | +17.3% | 73,500 | -16.5% | 0.00% | 0.0% |
| Q1 2023 | $3,959,120 | -12.1% | 88,000 | -14.4% | 0.00% | 0.0% |
| Q4 2022 | $4,503,668 | +19.7% | 102,800 | +80.0% | 0.00% | 0.0% |
| Q3 2022 | $3,762,000 | +464.0% | 57,100 | +332.6% | 0.00% | – |
| Q2 2022 | $667,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 103,900 | $5,217,858 | 0.02% |
| JANE STREET GROUP, LLC | 147,200 | $7,392,384 | 0.00% |
| SIMPLEX TRADING, LLC | 38,600 | $1,938 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |